April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Biofrontera (BFRI) stock forecast for 2024
Updated: April 25, 2024 (09:49)
Sector: HealthcareThe share price of Biofrontera Inc. (BFRI) now
50/200 Day Moving Average: $1.336 / $4.825
This figure corresponds to the Average Price over the previous 50/200 days. For Biofrontera stocks, the 50-day moving average is the resistance level today.
For Biofrontera stocks, the 200-day moving average is the resistance level today.
Are you interested in Biofrontera Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biofrontera stock price in 2024. How much will one Biofrontera share be worth in 2024? Is it worth taking profit / loss on BFRI stock now or waiting? What are analysts' forecasts for Biofrontera stock?
We forecast Biofrontera stock performance using neural networks based on historical data on BFRI stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Biofrontera Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Biofrontera analysts is $16. Today 200 Day Moving Average is the resistance level (4.825 $). 50 Day Moving Average is the support level (1.336 $).
Historical and forecast chart of Biofrontera Inc. stock
The chart below shows the historical price of Biofrontera stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BFRI stock price can be found in the table below.
Biofrontera AG is a German biopharmaceutical company. The company develops medicines and medicinal cosmetics for the treatment of skin diseases and regenerative care for damaged skin. His portfolio includes: Ameluz, a photodynamic therapy (PDT) for actinic keratoses in development for other types of skin cancer and warts; BF-RhodoLED PDT lamp, used after treatment with Ameluz to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itchy, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The company is also in the clinical development of two candidate drugs: BF-derm1, a tablet with an inhibitor that blocks the synthesis of histamine in cells, which causes allergic reactions, and BF1, a selective serotonin receptor for the prevention of migraine. The company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MMF.
Biofrontera (BFRI) Forecast for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May | 1.71 | 1.63 | 1.80 | 9.41 % |
| Jun | 1.76 | 1.59 | 1.88 | 15.50 % |
| Jul | 1.85 | 1.73 | 2.09 | 17.37 % |
| Aug | 1.71 | 1.60 | 1.84 | 12.72 % |
| Sep | 1.45 | 1.39 | 1.59 | 12.18 % |
| Oct | 1.48 | 1.40 | 1.65 | 14.85 % |
| Nov | 1.44 | 1.27 | 1.61 | 21.04 % |
| Dec | 1.36 | 1.30 | 1.44 | 9.50 % |
Biofrontera information and performance
120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, US
Market capitalization of the Biofrontera Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BFRI shares in the company outstanding by the market price of one share.
EBITDA of Biofrontera is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Biofrontera price target for 2024 by month
Target values for the price of one Biofrontera share for May 2024.
In May, the Positive dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 9.409% volatility is expected.
Pessimistic target level: 1.63
Optimistic target level: 1.80
Target values for the price of one Biofrontera share for Jun 2024.
In Jun, the Positive dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 15.500% volatility is expected.
Pessimistic target level: 1.59
Optimistic target level: 1.88
Target values for the price of one Biofrontera share for Jul 2024.
In Jul, the Positive dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 17.369% volatility is expected.
Pessimistic target level: 1.73
Optimistic target level: 2.09
Target values for the price of one Biofrontera share for Aug 2024.
In Aug, the Negative dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 12.719% volatility is expected.
Pessimistic target level: 1.60
Optimistic target level: 1.84
Target values for the price of one Biofrontera share for Sep 2024.
In Sep, the Negative dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 12.180% volatility is expected.
Pessimistic target level: 1.39
Optimistic target level: 1.59
Target values for the price of one Biofrontera share for Oct 2024.
In Oct, the Positive dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 14.850% volatility is expected.
Pessimistic target level: 1.40
Optimistic target level: 1.65
Target values for the price of one Biofrontera share for Nov 2024.
In Nov, the Negative dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 21.042% volatility is expected.
Pessimistic target level: 1.27
Optimistic target level: 1.61
Target values for the price of one Biofrontera share for Dec 2024.
In Dec, the Negative dynamics for Biofrontera Inc. shares will prevail with possible monthly volatility of 9.499% volatility is expected.
Pessimistic target level: 1.30
Optimistic target level: 1.44
Related stocks from Healthcare sector
